Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
Follow ZBH
Alert me
Zimmer Biomet Holdings, Inc. (ZBH) Debt to equity
Zimmer Biomet Holdings, Inc.'s debt to equity at the end of the quarter to 30 September 2026 was 0.6×, down 0.0× from fiscal 2025 (0.6×). Over the past ten years it has ranged from 0.5× (fiscal 2023) to 1.2× (fiscal 2015); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of 0.0× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.6× | 19.00% |
| FY2024 | 0.5× | 7.66% |
| FY2023 | 0.5× | (2.47%) |
| FY2022 | 0.5× | (15.14%) |
| FY2021 | 0.6× | (16.21%) |
| FY2020 | 0.7× | 0.41% |
| FY2019 | 0.7× | (16.31%) |
| FY2018 | 0.8× | (8.28%) |
| FY2017 | 0.9× | (25.65%) |
| FY2016 | 1.2× | (0.01%) |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | 0.6× | (0.39%) |
| Jun 2026 | 0.6× | 0.49% |
| Mar 2026 | 0.6× | (0.46%) |
| Dec 2025 | 0.6× | (6.88%) |
| 43 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| GMED Globus Medical, Inc. compare | 0.0× |
| PEN Penumbra, Inc. compare | 0.0× |
| GKOS Glaukos Corporation compare | 0.1× |
| STE STERIS plc compare | 0.3× |
| DXCM DexCom, Inc. compare | 0.5× |
| ZBH Zimmer Biomet Holdings, Inc. | 0.6× |
| PHG Koninklijke Philips N.V. compare | 0.6× |
| PODD Insulet Corporation compare | 0.6× |
| SNN Smith & Nephew SNATS, Inc. compare | 0.6× |
| Medical Devices industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement